Recruiting PHASE3 INTERVENTIONAL 2-arm
NCT07142408
The Effect of Bacterial Decolonization Before Skin Cancer Surgery on Infection Rate of Lower Extremity Wounds Left Open to Heal
The Effect of Pre-Operative Bacterial Decolonization on Post-Operative Infection Rate for Lower Extremity Wounds Healing by Second Intention
Sponsor: Baylor College of Medicine
Conditions
Surgical Wound Infection
Interventions
Chlorhexidine gluconate (4%) Mupirocin 2% Ointment
Updated 1 time since 2025 Last updated: Aug 22, 2025 Started: Mar 13, 2023 Primary completion: Oct 31, 2030 Completion: Dec 31, 2030
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
Listed as NCT07142408, this PHASE3 trial focuses on Surgical Wound Infection and remains actively recruiting participants. Sponsored by Baylor College of Medicine, it has been updated 1 time since 2023, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.
Status Flow
Change History
1 version recorded Recruiting — PHASE3
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Baylor College of Medicine
- Princeton Healthcare System
- St. Luke's Hospital and Health Network, Pennsylvania
- The Cleveland Clinic
- The Cooper Health System
- University of California, Davis
- University of Georgia
- Washington University School of Medicine
Data source: The Cooper Health System
For direct contact, visit the study record on ClinicalTrials.gov .